A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study (Q33376981)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study |
scientific article |
Statements
1 reference
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study (English)
1 reference
Maryam Fouladi
1 reference
H Stacy Nicholson
1 reference
Tianni Zhou
1 reference
Fred Laningham
1 reference
Kathleen J Helton
1 reference
Emi Holmes
1 reference
Kenneth Cohen
1 reference
Rose Anne Speights
1 reference
John Wright
1 reference
Ian F Pollack
1 reference
Children's Oncology Group
1 reference
1 December 2007
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference